Asymptomatic Severe Aortic Stenosis in the Elderly: When to Intervene

Asymptomatic Severe Aortic Stenosis in the Elderly: When to InterveneThis work studies the natural history of aortic stenosis and the optimal timing to intervene elderly patients with asymptomatic severe aortic stenosis.

 

This disease is increasingly misdiagnosed in the elderly population, and this goes hand in hand with enhanced therapeutic options.

 

Prior studies on the natural history of this disease were made on much younger populations (between 60 and 70) and it was these studies clinical guidelines were based on.

 

Deciding when to intervene elderly patients based on guidelines written for younger patients, could lead to serious mistakes. This is the first work to study the natural history of aortic stenosis in elderly patients. 

 

A total of 103 consecutive >70 patients (mean age 77±5 years) with asymptomatic severe aortic stenosis (peak systolic velocity 4.7±0.6 m/s) were followed up prospectively.

 

During follow up, there were 91 events, including aortic valve replacement indication in 82 patients, and cardiac death in 9 patients. Event free survival rate was:

  • 73% at one year
  • 43% at two years
  • 23% at three years
  • 16% at four years

 

Symptoms onset was severe (functional class ≥3) in 43% of the population.

 

Patients with peak systolic velocity ≥5 m/s presented:

  • 21% event free survival rate at two years
  • 4% event free survival rate at four years.

 

Patients with peak systolic velocity <5 m/s (p<0.001) presented:

  • 57% event free survival rate at two years
  • 23% event free survival rate at four years

 

Seventy one patients received aortic valve replacement and postop survival rate was 89% at one year and 77% at 3 years after procedure.

 

Conclusion

It might be difficult to detect mild symptoms in elderly patients with asymptomatic severe aortic stenosis, even when closely monitored.  We should expect a high events rate, and cardiac death at symptom onset is not infrequent.

[plain]

 

Because of this, elective aortic valve replacement should be considered particularly in patients with more than 5 m/s peak velocity and relatively low periprocedural risk.

[/plain]

 

Original Title: Asymptomatic Severe Aortic Stenosis in the Elderly.

Reference: Robert Zilberszac et al. J Am Coll Cardiol Img 2017;10:43–50.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...

Valve-in-Valve in Small Surgical Aortic Bioprostheses: Balloon-Expandable or Self-Expanding? Three-Year Results from the LYTEN Trial

Dysfunction of small surgical aortic bioprostheses represents a challenging scenario for transcatheter aortic valve replacement in the valve-in-valve setting, due to the higher incidence...

Can TAVI Be Safely Performed in Patients With Bicuspid Aortic Valve?

Bicuspid aortic valve (BAV) represents an anatomical challenge for transcatheter aortic valve replacement (TAVR) due to the frequent presence of elliptical annuli, fibroc calcific...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...